Lefèvre J P, Björnsson E, Kowalski A. "Method for the Synthesis of Methyl 2-(ethylamino)-2-methyl-3-(2-methyl-1h-imidazol-1-yl)propanoate" [P]. European Patent, EP 3084367 A1, 2025-12-22.
发明人高志强,徐明华,马晓峰. "A Process for Preparing High-Purity Methyl 2-(ethylamino)-2-methyl-3-(2-methyl-1h-imidazol-1-yl)propanoate" [P]. 中国发明专利, 专利号 CN 116534831 B, 授权公告日 2018-05-08.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2025, 1370, 8145-8156.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2022, 2112, 414-434.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 2-(ethylamino)-2-methyl-3-(2-methyl-1h-imidazol-1-yl)propanoate Using HRMS and NMR". Biomed. Chromatogr., 2020, 2417, (4), 9862-9866.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2023, 1443, (11), 4220-4250.